Objective To study the effect of different doses of caffeine citrate on the treatment of premature infants with primary apnea,so as to provide evidence for the appropriate use of caffeine citrate in clinical practice.Methods A total of 133 cases of premature infants diagnosed with primary apnea in the neonatal intensive care unit of the Second Hospital of Shandong University were selected from January 2015 to June 2016. Caffeine citrate was used to treat apnea,and the children were randomly divided into high-dose group (n=85) and low-dose group (n=50) according to the maintenance dose. In both groups,20 mg/(kg·d) caffeine citrate was used as the loading dose,which was maintained for 24 hours. After that,8—10 mg/(kg·d) caffeine citrate was given in the high-dose group and 5—7.9 mg /(kg·d) in the low-dose group. After 5 days of treatment,the effective rate of treatment,changes in attack frequency,changes in severity and ventilator utilization rate were compared between the two groups. Results The effective rate of treatment in high-dose group(86.0%) was significantly higher than that of low-dose group(72.0%),the average number of apnea episodes and severity of apnea were significantly lower in high-dose group(P＜0.05),while the difference on ventilator utilization rate between the two groups was not significant(P＞0.05). Also,children were divided into two groups according to their gestational age at birth,including <32 weeks and ≥32 weeks. The average number of apnea episodes and severity of apnea in high-dose group were significantly lower than those in low-dose group in the same gestational age group (P＜0.05). While there were no significant differences on apnea episodes and severity of apnea between different gestational age groups at the same dose(P＞0.05). Besides,the incidence of adverse reactions between the two groups was not significantly different either (P＞0.05). Conclusion Caffeine citrate is more effective in treating premature infants with apnea at maintenance of 8—10 mg/(kg·d ) than maintenance of 5—7.9 mg/(kg·d ),which does not increase the incidence of adverse reactions.
Key words
caffeine citrate /
apnea /
premature infants
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 邵肖梅,叶鸿瑁,丘小汕. 实用新生儿学[M].4版.北京:人民卫生出版社,2011:245-247.
[2]Horne RSC,Fung ACH,NcNeil S,et al. The longitudinal effects of persistent apnea on cerebral oxygenation in infants born preterm[J]. J Pediatr,2017,182:79-84.
[3] Di Fiore JM,Martin RJ,Gauda EB.Apnea of prematurity- perfect storm[J].Respir Physiol Neurobiol,2013,189(2):213-222.
[4] Gerull R,Manser H,Küster H,et al.Increase of caffeine and decrease of corticosteroids for extremely low-birthweight infants with respiratory failure from 1997 to 2011[J].Acta Paediatrica,2013,102(12):1154-1159.
[5]Dobson NR,Hunt CE.Caffeine:an evidence-based success story in VLBW pharmacotherapy[J].Pediatr Res,2018,84(3):333-340.
[6]Poets CF.Apnea of prematurity:what can observational studies tell us about pathophysiology[J].Sleep Med,2010,11(7):701-707.
[7] 杜立中.极低体重儿呼吸暂停的有关问题[J].中国实用儿科杂志,2002,17(7):393-396.
[8] 袁琳,陈超.咖啡因在新生儿中的临床应用[J].世界临床药物,2009,30(9):518-522.
[9] 杜立中.早产儿呼吸暂停的药物治疗[J].中国实用儿科杂志,2015,30(2):88-92.
[10] 唐晓艳.王丹华.咖啡因在新生儿中的应用进展[J].中国新生儿科杂志,2014,29(5):343-346.
[11] Dobson NR,Patel RM,Smith PB,et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants[J].J Pediatr,2014,164(5):992-998.
[12] Gupte AS,Gupta D,Ravichandran S,et al. Effect of early caffeine on neurodevelopmental outcome of very low-birth weight newborns[J]. J Matern Fetal Neonatal Med,2016,29(8):1233-1237.
[13] Lodha A,Seshia M,McMillan DD. Association of early caffeine administration and neonatal outcomes in very preterm neonates[J]. JAMA Pediatr,2015,169(1):33-38.
[14] Dayanim S,Lopez B,Maisonet TM,et al.Caffeine induces alveolar apoptosis in the hyperoxia-exposed developing mouse lung[J].Pediatr Res,2014,75:395-402.
[15] 魏彦敏,齐卫斌,翟娜,等. 咖啡因治疗超低出生体质量儿呼吸暂停的最佳剂量探究[J].临床合理用药,2015,8(2A):100,102.
[16] Leon AE,Michienzi K,Ma CX,et al. Serum caffeine concentrations in preterm neonates[J]. Am J Perinatol,2007,24(1):39-47.
[17] Mohammed S,Nour I,Shabaan AE,et al. High versus low-dose caffeine for apnea of prematurity:a randomized controlled trial[J]. Eur J Pediatr,2015,174(7):949-956.
[18] Crossley KJ,Allison BJ,Polglase GR,et al. Effects of caffeine on renal and pulmonary function in preterm newborn lambs[J]. Pediatr Res,2012,72(1):19-25.
PDF(569 KB)
